Jane Chung, MD
- Associate Program Director, Vascular Surgery, UH Cleveland Medical Center
- Specialty: Vascular Surgery
-
Location:UH Cleveland Medical Center Mather
11100 Euclid Ave
Cleveland, OH 44106
- Call: 216-844-3013
Biography: Jane Chung, MD
Certifications & Memberships
- Surgery - American Board of Surgery
Education
Fellowship | Vascular Surgery
Vascular Surgery - UH Cleveland Medical Center (2021 - 2023)
Residency | General Surgery
General Surgery - Augusta University Medical Center (2016 - 2021)
Medical Education
Medical College Of Georgia (2016)
Undergraduate
Emory University (2011)
About
Jane Mi Chung, MD, is a vascular surgeon and endovascular specialist at University Hospitals Harrington Heart & Vascular Institute.
Dr. Chung earned her medical degree from the Medical College of Georgia. Her postdoctoral training included a general surgery residency at Augusta University Medical Center followed by a vascular surgery fellowship at University Hospitals Cleveland Medical Center and Case Western Reserve University. During her training, Dr. Chung served as a research study coordinator at St. Mary’s Center for Wound Healing and a research specialist at Emory University School of Medicine where she assisted with National Institutes of Health (NIH) funded studies in geriatric populations.
Dr. Chung is board certified in vascular surgery with experience in diagnosing and treating the full range of vascular diseases. She has authored nearly 30 publications and presented at regional and national medical conferences on related treatment techniques such as transcarotid artery revascularization, thoracic endografts for thoracic aortic aneurysms, autologous vein bypass grafts and endovascular treatment of visceral artery aneurysms.
Dr. Chung is a member of several national medical organizations including the American College of Surgeons, Society of Vascular Surgery and Society of Clinical Vascular Surgery.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Jane Chung did not disclose any Outside Relationships with Industry.